Gm14496 inhibitors represent a class of chemical compounds specifically designed to target and block the activity of the Gm14496 gene product. Gm14496 is part of the mouse genome, and although not fully characterized, it is believed to play a role in important cellular functions, potentially involving regulatory processes such as gene expression, signal transduction, or protein modification. Inhibitors targeting Gm14496 are intended to disrupt its function, either by preventing its interaction with other proteins or molecules or by directly blocking any catalytic activity it might have. These inhibitors help scientists explore how the loss of function of this gene impacts cellular homeostasis and various biological pathways.
By using Gm14496 inhibitors in research, scientists can gain insights into the specific role this gene plays in the broader cellular context. Blocking Gm14496 allows researchers to observe changes in cellular behavior, including potential disruptions in signaling pathways, gene regulatory networks, or metabolic processes that depend on this gene's activity. Moreover, Gm14496 inhibitors provide valuable information about the gene's interactions with other cellular components, which can help to map its role within complex molecular systems. Studying these inhibitors also sheds light on how the inhibition of Gm14496 influences the overall function and regulation of biological processes, offering a deeper understanding of how this gene fits into the larger picture of cellular organization and molecular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inhibitor of G protein-coupled receptor (GPCR) signaling. Pertussis Toxin interferes with GPCR activity, potentially impacting Gm14496's function as a predicted G protein-coupled receptor, preventing downstream signaling cascades associated with GPCRs. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Broad-spectrum GPCR inhibitor. Suramin targets GPCRs, potentially influencing Gm14496's activity as a predicted G protein-coupled receptor, blocking ligand binding and downstream signaling, and thus inhibiting cellular responses associated with GPCR activation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P receptor antagonist impacting GPCR signaling. Sphingosine-1-phosphate antagonizes S1P receptors, potentially disrupting Gm14496's function as a GPCR, leading to the inhibition of downstream signaling pathways associated with GPCR activation. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gβγ inhibitor affecting GPCR signaling. Gallein specifically inhibits Gβγ subunits, potentially modulating Gm14496's GPCR activity by disrupting Gβγ-mediated signaling cascades and subsequently inhibiting cellular responses associated with GPCR activation. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
Gq protein inhibitor influencing GPCR signaling. YM-254890 targets Gq proteins, potentially impacting Gm14496's function as a GPCR by disrupting Gq-mediated signaling pathways and inhibiting downstream cellular responses associated with GPCR activation. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
P2X receptor antagonist affecting GPCR signaling. NF449 inhibits P2X receptors, potentially impacting Gm14496's function as a GPCR by disrupting P2X receptor-mediated signaling pathways and subsequently inhibiting cellular responses associated with GPCR activation. | ||||||